Patent Update Central & Peripheral Nervous Systems: Glycine-site NMDA receptor antagonists: an update
- 1 October 1996
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 6 (10) , 1069-1079
- https://doi.org/10.1517/13543776.6.10.1069
Abstract
Animal models predict that antagonists acting at the glycine-site of the N-methyl-D-aspartate (NMDA) receptor have potential in the treatment of stroke, head injury, epilepsy and schizophrenia, and may offer considerable therapeutic advantage over other classes of NMDA antagonists. Recent developments, particularly in the patent literature, are reviewed for the period since June 1995. The available data on three compounds believed to be in clinical development, namely GV150526A (Glaxo Wellcome), ACEA 1021 (CoCensys/Ciba-Geigy) and ZD9379 (Zeneca), are highlighted. Other compound classes discussed include quinoxaline-2,3-diones and analogues, imidazolopyrazinones, pyridone derivatives, benzazepinediones, 2-carboxyindoles, pyridazinoquinolines and miscellaneous other compounds.Keywords
This publication has 14 references indexed in Scilit:
- 3-Hydroxy-quinolin-2-ones: Inhibitors of [3H]-glycine binding to the site associated with the NMDA receptorBioorganic & Medicinal Chemistry Letters, 1996
- 1-Hydroxy-1,4-dihydroquinoxaline-2,3-diones: Novel antagonists at NMDA receptor glycine sitesBioorganic & Medicinal Chemistry Letters, 1996
- Synthesis and biological activity of a series of 4-aryl substituted benz[b]azepines: Antagonists at the strychnine-insensitive glycine siteBioorganic & Medicinal Chemistry Letters, 1995
- Review Central & Peripheral Nervous Systems: Glycine-site NMDA receptor antagonistsExpert Opinion on Therapeutic Patents, 1995
- Synthesis and Structure-Activity Relationships of Substituted 1,4-Dihydroquinoxaline-2,3-diones: Antagonists of N-Methyl-D-aspartate (NMDA) Receptor Glycine Sites and Non-NMDA Glutamate ReceptorsJournal of Medicinal Chemistry, 1995
- 5,6,7,8-Tetrahydroquinolones as antagonists at the glycine site of the NMDA receptorBioorganic & Medicinal Chemistry Letters, 1995
- In vivo Models of Cerebral Ischemia: Effects of Parenterally Administered NMDA Receptor Glycine Site AntagonistsJournal of Cerebral Blood Flow & Metabolism, 1995
- The Neuroprotective Effect of the Glycine Site Antagonist 3R-(+)-cis-4-Methyl-HA966 (L-687,414) in a Rat Model of Focal IschaemiaJournal of Cerebral Blood Flow & Metabolism, 1995
- The anticonvulsant and behavioural profile of L‐687,414, a partial agonist acting at the glycine modulatory site on the N‐methyl‐D‐aspartate (NMDA) receptor complexBritish Journal of Pharmacology, 1994
- The Glycine Site on the NMDA Receptor: Structure-Activity Relationships and Therapeutic PotentialJournal of Medicinal Chemistry, 1994